Summer Sale

50% off Premium Yearly

00days
00hrs
00mins
00secs
HMP.TO 0.03SPGP 1ZUQ.TO 0.55NVDA 0.32GL 1.66MRK -1.71IEMG 0.5GEV 33.87
Novelion (NVLN.TO)
The ultimate 360° Tracker Your financial life in one place, automatically

Novelion (NVLN.TO)

0.00
-0.00 (0.00%)
52 watching
Icon Financials Financials Icon Analysis Technical Analysis
Interactive Chart
1w 1m 6m 1y
0
BUY

Novelion(NVLN.TO)

Jun 25, 2001
Buying companies for pipelines. Price is good.
Photo of John ZechnerJohn ZechnerUnlock Rating
$27.50

Stock price when the opinion was issued

biotechnologypharmaceutical
DON'T BUY

Novelion(NVLN.TO)

Jun 20, 2001
Not one of the stronger biotechs. Prefers Biovale.
Photo of David BurrowsDavid BurrowsUnlock Rating
$29.60

Stock price when the opinion was issued

biotechnologypharmaceutical
BUY

Novelion(NVLN.TO)

Jun 14, 2001
A phase 3 trial needed more data. Will take longer. OK long term hold.
Photo of Robert FloydRobert FloydUnlock Rating
$29.39

Stock price when the opinion was issued

biotechnologypharmaceutical
TOP PICK

Novelion(NVLN.TO)

Jun 13, 2001
Likes the health care sector and their product Visodine.
Photo of Ted MacklinTed MacklinUnlock Rating
$29.99

Stock price when the opinion was issued

biotechnologypharmaceutical
DON'T BUY

Novelion(NVLN.TO)

Jun 04, 2001
Still waiting for FDA approval. Probably no movement in the short term and in the long run needs more products in the pipe.
Photo of David DriscollDavid DriscollUnlock Rating
$33.00

Stock price when the opinion was issued

biotechnologypharmaceutical
BUY

Novelion(NVLN.TO)

May 31, 2001
Likes, even though its volatile. Good long term potential.
Photo of Nereo PiticcoNereo PiticcoUnlock Rating
$32.48

Stock price when the opinion was issued

biotechnologypharmaceutical
BUY

Novelion(NVLN.TO)

May 30, 2001
Good company. Visodine has been approved and sales are starting. Volatile
Photo of Richard StoneRichard StoneUnlock Rating
$32.90

Stock price when the opinion was issued

biotechnologypharmaceutical
BUY

Novelion(NVLN.TO)

May 28, 2001
Has a good drug. Long term hold.
Photo of Bruce Campbell (1)Bruce Campbell (1)Unlock Rating
$33.75

Stock price when the opinion was issued

biotechnologypharmaceutical
DON'T BUY

Novelion(NVLN.TO)

May 25, 2001
A one trick pony.
Photo of John ZechnerJohn ZechnerUnlock Rating
$33.74

Stock price when the opinion was issued

biotechnologypharmaceutical
TOP PICK

Novelion(NVLN.TO)

May 23, 2001
Great product. A one trick pony. At a low price.
Photo of Ted MacklinTed MacklinUnlock Rating
$33.50

Stock price when the opinion was issued

biotechnologypharmaceutical
BUY

Novelion(NVLN.TO)

May 14, 2001
Analysts expect some good things and have big targets.
Photo of Robert FloydRobert FloydUnlock Rating
$32.99

Stock price when the opinion was issued

biotechnologypharmaceutical
TOP PICK

Novelion(NVLN.TO)

May 08, 2001
Good drug product which is now being marketed.
Photo of Mike WeirMike WeirUnlock Rating
$39.29

Stock price when the opinion was issued

biotechnologypharmaceutical
BUY ON WEAKNESS

Novelion(NVLN.TO)

May 04, 2001
Still a lot of upside left. Generating cash flow. Buy on weakness.
Photo of Glenn Paradis, BA, CFAGlenn Paradis, BA, CFAUnlock Rating
$39.65

Stock price when the opinion was issued

biotechnologypharmaceutical
DON'T BUY

Novelion(NVLN.TO)

May 02, 2001
Expensive. Possible patent infringement. Too much risk.
Photo of Gordon Higgins, CA, MBAGordon Higgins, CA, MBAUnlock Rating
$39.20

Stock price when the opinion was issued

biotechnologypharmaceutical
TOP PICK

Novelion(NVLN.TO)

Apr 26, 2001
Very good biotech. Profitable. Good price now. A thin pipeline.
Photo of John Sinkins, CFAJohn Sinkins, CFAUnlock Rating
$39.85

Stock price when the opinion was issued

biotechnologypharmaceutical
Showing 151 to 165 of 190 entries

Build your watch list

Sign in to track investments
you care about

Latest Buy Signals

EPD -0.03$37.25
ET 0.31$19.07
MAIR 0$
RKLB -12.39$102.39
SESG-O 0$

Today's Top Picks

HMP.TO 0.03$9.75
SPGP 1$120.39
ZUQ.TO 0.55$107.47
NVDA 0.32$205.19
GL 1.66$166.76

Popular Articles

Latest Sell Signals

PRGO 0.09$10.99
CBRS 0$
HAWK 0$
AVEX 0$
SWMR 0$

Most Recent Experts

Jim Cramer - Mad Money

Jim Cramer - Mad Money

CNBC

Richard Orrell

Richard Orrell

RN Croft Financial Group

Stockchase Insights

Stockchase Insights

5i Research

The Panic-Proof Portfolio (Stockchase Research)

The Panic-Proof Portfolio (Stockchase Research)

Stockchase Premium

Stan Wong

Stan Wong

Private Wealth Management, ScotiaMcleod

disclaimer

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at: [email protected].

About usHow to useContact Us
More...
AdvertisingIn the newsPrivacy PolicyTerms of service
FacebookX
© 2000 - 2026 Stockchase Inc. by Wealthica